Free Trial

Relief Therapeutics (RLFTF) SEC Filings & 10K Form

Relief Therapeutics logo
$2.63 -0.08 (-2.77%)
As of 04/1/2025 10:36 AM Eastern

Recent Relief Therapeutics SEC Filings

DateFilerForm TypeView
03/27/2025
3:30 PM
JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
Relief Therapeutics (Subject)
Form F-6 POS
12/17/2024
4:20 PM
Relief Therapeutics (Filer)
Form 424B3
12/17/2024
3:54 PM
Relief Therapeutics (Filer)
Form 15F-12G
11/12/2024
4:00 PM
Relief Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
4:30 PM
Relief Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/09/2024
3:30 PM
Relief Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/23/2024
3:30 PM
Relief Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/19/2024
3:47 PM
Relief Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/04/2024
4:11 PM
Relief Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2024
3:30 PM
Relief Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2024
3:31 PM
Relief Therapeutics (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (OTCMKTS:RLFTF) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners